Chi-Ming Chow, M.D., MSc, FRCPC, FACC, FASE, attending staff cardiologist, St. Michael's Hospital, and associate professor, Department of Medicine, University of Toronto, discusses new technology trends in ultrasound and what developments will effect the future of cardiac ultrasound. Read the article "Automation Enhances, Streamlines Echocardiography." Chow also discusses advancements in strain imaging and how this diagnostic tool is becoming more important. Watch this VIDEO session on the basics of cardiac strain imaging from the American Society of Echocardiography (ASE) 2016.
VIDEO: Cardiovascular Damage Caused by Chagas Disease
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar Health Research Institute, Washington, D.C., spoke about the cardiovascular impact of chagas disease and the symptoms that should be considered for patients who are from, or visited, South or Central America. He spoke on the topic at the 2019 American Society Of Echocardiography (ASE) meeting.
Chagas, also called trypanosomiasis, is a tropical parasitic disease caused by the protist Trypanosoma cruzi. It is spread through the bite of the triatominae insect, which is also known as the "kissing bug." Link to the Center for Disease Control (CDC) page on Chagas.
Asch served as the co-chair of the group that created the guidelines to image Chagas disease.
Read the guidelines at "Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in Collaboration With the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC).
Andrea Natale, M.D., FACC, FHRS, FESC, executive medical director, Texas Cardiac Arrhythmia Institute at St. David's Medical Center, discusses how to build an electrophysiology (EP) program at the 2017 Heart Rhythm Society annual meeting. Read the article "Growing a Cardiac Rhythm Program in a Community Setting."
Lucas Boersma, M.D., Ph.D., FESC, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands, discusses how subcutaneous implantable cardioverter defibrillator (S-ICD) technology works, selecting patient appropriate patients and new S-ICD technologies in development at the 2017 Heart Rhythm Society annual meeting. Read the article "Subcutaneous ICD System Shows Positive Outcomes in Largest Real-world Study."
Watch the related VIDEO: How to Install a Subcutaneous ICD System
Read the related article New Technology and Market Challenges Facing Implantable Cardioverter Defibrillators.
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 2017 Heart Rhythm Society (HRS) annual meeting. Learn more about the Heart Rhythm Society 2017 late-breaking electrophysiology trials.
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative Transesophegeal Echo (TEE) for Left Ventricular Assist Devices (LVAD)." It is presented by Kent Rehfeldt, M.D., FASE, associate professor of anesthesiology, Mayo Clinic, Rochester, Minn. This is one of the educational seminars presented at the ASE 2016 annual scientific sessions, one of the premier meetings for cardiac ultrasound education. For more information, visit asescientificsessions.org.
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Strain Fundamentals Made Easy - Strain in Routine clinical Practice: Knobology and Beyond." It is presented by Teerapat Yingchocharoen, M.D., FASE, from Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. He is also a co-director of the Echo ASE ASEAN conference. This is one of the sessions presented at the ASE 2016 annual scientific sessions, one of the premier meetings for cardiac ultrasound education. For more information, visit asescientificsessions.org.
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancements in lead management technology at the 2017 Heart Rhythm Society (HRS) annual meeting. Read the article “ Study Shows Occlusion Balloon Saves Lives During Lead Extraction.” Read the articles “Advances in Transvenous Lead Extraction,” and “Strategies, New Technologies Aid Lead Management.”
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital, N.Y., discusses advancements in leadless pacemaker technology at the 2017 Heart Rhythm Society (HRS) annual meeting. Read the articles “Leadless Endocardial CRT Pacing Effective for Heart Failure Patients,” and “New Data Showcases Long-term Benefits of Nanostim Leadless Pacemaker.”
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation Endocardially for cardiac resynchronization therapy) leadless CRT pacing system for heart failure patients. Read the article “Leadless Endocardial CRT Pacing Effective for Heart Failure Patients.”
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopkins Hospital, discusses advancements in AF ablation at the 2017 Heart Rhythm Society (HRS) annual meeting. Read about the new AF expert consensus statement released at HRS 2017.
VIDEO: Current State of Atrial Fibrillation Ablation Technologies — Interview with Hugh Calkins, M.D.,
VIDEO: Cryoballoon Ablation Best Practice Guidelines — Wilber Su, M.D.
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidental tears in the superior vena cava (SVC) during EP device lead extraction procedures. A review of post-market release data shown it can bridge the patient to open surgical repair and significantly reduce the usual 50 percent mortality associated with this complication. Read the article about the late-breaking clinical trial presentation from Heart Rhythm 2017.
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS). The device is a leadless pacemaker for single chamber pacing and eliminated the need for a surgical pocket or transvenous leads. The design concept is to simplify pacemaker implantation and eliminate the need for leads, which open the patient up to additional device and infection complications.
Watch the VIDEO “Current State of Leadless Pacemaker Technology,” an interview with Vivek Reddy, M.D., at the Heart Rhythm Society 2017 meeting.
Read the 2018 article "New Pacemaker Technologies."
Kim A. Williams, Sr., M.D., chief of cardiology at Rush University Medical Center, Chicago and former president of both the American College of Cardiology (ACC) and the American Society of Nuclear Cardiology (ASNC), explains the impact of healthcare reform on cardiology and specifically on nuclear perfusion imaging. Read the article "HHS Finalizes Cardiology Bundled Payment Model to Lower Healthcare Costs."
Tom Kloetzly, sales and marketing VP for Shimadzu Medical Systems USA, explains the evolution of Shimadzu Corporation since its founding 142 years ago. Kloetzly focuses on the Trinias Interventional X-ray line shown at RSNA 2016. Kloetzly states “A key feature of Trinias, is the ability to image from fingertip to fingertip during a transradial approach which makes for much shorter hospital stay with the patient up and moving almost immediately after the procedure. Features Like RSM-DSA, a type of motion correction subtraction, eliminates patient movement during acquisition while STENTVIEW, is an enhanced visualization during stent placement in real-time." For more information: www.shimadzu.com/med/products/angio/index.html.
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), discusses advancements in nuclear imaging and some of the issues facing the subspecialty. Read the article “PET vs. SPECT — Will PET Dominate Over the Next Decade?”
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit. He presented a late-breaking study on the outcomes for 15,259 U.S. patients with acute MI in cardiogenic shock supported with the Impella percutenous ventricular assist device. Read more about the Detroit Cardiogenic Shock Initiative.
The shift to value-based payment models requires focused attention on quality and cost. Lumedx’s Cardiovascular Performance Program offers a new approach to managing this transition so hospitals can improve outcomes — and dramatically reduce costs. See how complications reduction, cost-per-case variations and other key metrics delivered in real-time can drive radical change. For more information, visit www.lumedx.com.
A discussion with Heart Rhythm Society (HRS) President Michael Gold, M.D., Ph.D., director of cardiology and associate dean at the Medical University of South Carolina (MUSC), at the American College of Cardiology 2017 annual meeting. He discusses advances to treat atrial fibrillation, new ablation and electro mapping technologies and innovations in implantable devices.
DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo floor at the 2017 meeting of the American College of Cardiology (ACC). For key technology trends at ACC.17, watch the VIDEO "Cardiac Technology Trends at ACC.17."
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the two year outcomes of the ABSORB III trial of Absorb vs. Xience. The late-breaking trial was presented at ACC 2017. Read the article on the ABSORB III results. Watch a VIDEO with Gregg Stone, M.D., "Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries."
MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017 American College of Cardiology (ACC) Scientific Sessions. For a list of late-breaking trials and links to related articles read "ACC 2017 Late-Breaking Trials." Watch a VIDEO of Watson's assessment of trends at ACC.16.
Michael Reardon, M.D., professor of cardiothoracic surgery at Houston Methodist DeBakey Heart and Vascular Center, discusses the positive results of the SURTAVI trial that were presented at ACC.17. Reardon was the principal investigator for the SURTAVI trial. Read the article "TAVR Stands Equal to Surgical Valve Replacement."
Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital, detail the positive results of the DEFINE-FLAIR and IFR-SWEDEHEART trials presented at ACC.17. Read the article “Easier to Use iFR Equal to Outcomes of FFR in Coronary Lesion Evaluation.”
Pam Rush, RN, MS, clinical program director, cardiovascular service line, and Craig Strauss, M.D., MPH, medical director, explain how MHI achieved significant savings by leveraging analytics software for reductions in patient complications, better vendor negotiations and other areas. Read the article “Advanced Analytics Software for Cardiology.”
ITN Editor Dave Fornell takes a tour of some of the most innovative new technology that was displayed on the expo floor at the 2017 Healthcare Information and Management Systems Society (HIMSS) annual meeting. The two most significant technology advances are discussed in Fornell's blog "Two Technologies That Offer a Paradigm Shift in Medicine at HIMSS 2017."
This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent. It became the first bifurcation stent cleared by the FDA in March 2017. The stent is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel. Read the articles "FDA Clears First Dedicated Coronary Bifurcation Stent" and "New Designs May Ease Bifurcation Stenting."
Enterprise imaging system expert Louis Lannum was in charge of Cleveland Clinic's efforts to connect images and other data from 33 of its departments into a single, centralized database that could deliver the content through a viewer in the electronic medical record. He spoke on the key requirements for enterprise imaging systems at HIMSS 2017. Read the article and watch related videos at "RSNA Technology Report 2016: Enterprise Imaging."
Machine learning is now being commercialized in medical imaging products designed to help improve workflow efficiency and augment the clinical user, not replace them. Steve Holloway with the U.K.-based healthcare market intelligence firm Signify Research discussed the expanding roles of artificial intelligence in imaging applications at the 2017 HIMSS healthcare IT conference. Read the article from HIMSS 2017 "How Artificial Intelligence Will Change Medical Imaging."
Ursula Wright, MSN/MBA, FNP-BC, from Mercy Health System, explains how the nation's fifth largest Catholic health system used heart failure pathways and order sets to reduce length of stay and $14 million in costs to treat heart failure patients. Mercy earned the 2016 HIMSS Enterprise Davies Award for its leverage of information technology to impact its clinical outcomes and reduce healthcare costs. Read the article “Device Technologies to Reduce Heart Failure Readmissions.”
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system. It was cleared by the FDA in early 2017. It uses an ECG lead vest to noninvasively create a 3-D electrophysiology (EP) electro-map of the heart to help identify arrhythmia and plan catheter ablation procedures. Read the related article on the technology.
Detailed imaging is needed to support complex interventions for the assessment and procedure guidance. See how the GE Healthcare cardiovascular ultrasound systems fit into the in Interventional space – from the Vivid E95 with cSound premium system to the Vivid iq compact system. For more information, go to www3.gehealthcare.com/en/products/categories/ultrasound/vivid/vivid_e95.
ITN and DAIC Editor Dave Fornell takes a tour of some of the most innovative new technologies being displayed on the expo floor at the Radiological Society of North America (RSNA) 2016 meeting. For key take away trends at RSNA, watch the video "Key Trends, New Technology at RSNA 2016."
This video, provided by Valtech, demonstrates the Cardioband transcatheter mitral annuloplasty system. It allows transcatheter repair of functional mitral regurgitation (FMR). It has a CE mark in Europe and a study to evaluate its safety and efficacy is planned in the United States. Read the article “Transcatheter Annuloplasty For Repair Versus Replacement in Functional Mitral Regurgitation.”
Mahadevappa Mahesh, MS, Ph.D., chief physicist and professor of radiology and radiological science at Johns Hopkins Hospital, explains the basics of medical imaging dose monitoring technologies. This includes monitoring and recording software meet new Joint Commission requirements, state dose laws and to improve patient safety regarding X-ray radiation exposure. Read the article “The Role of Dose Tracking Systems in Radiation Safety Programs.”
At RSNA 2016, the key buzzwords were “deep learning,” “machine learning” and “artificial intelligence.” Vendors and major academic centers are developing a wide array of artificial intelligence neuro networks to aid radiologists in clinical diagnosis and clinical decision support. Here are two examples of how the IBM Watson system examines a mammography and cardiac patient imaging studies. Watch the VIDEO “Development of Artificial Intelligence to Aid Radiology,” an interview with Mark Michalski, M.D., director of the Center for Clinical Data Science at Massachusetts General Hospital, explaining the basis of artificial intelligence in radiology.
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pittsburgh Medical Center, explains what is known about MRI contrast retention in the brain and other MRI safety concerns. He spoke to ITN at RSNA 2016. Read the article "Gadolinium May Remain in Brain after Contrast MRI."
Mark Michalski, M.D., director of the Center for Clinical Data Science at Massachusetts General Hospital, explains the basis of the utilization of artificial intelligence (aka deep learning and machine learning) in radiology. He also explains where things are at in development of these neuro networks at RSNA 2016. Watch the VIDEO “Examples of Artificial Intelligence in Medical Imaging Diagnostics.”
A post-game roundup by Imaging Technology News (ITN) Contributing Editor Greg Freiherr and Diagnostic and Interventional Cardiology (DAIC) and ITN Editor Dave Fornell on the trends and new tech seen on the show floor at the Radiological Society of North America (RSNA) 2016 meeting.
Shimadzu's latest generation interventional lab angiography imaging system, the Trinias, enables advanced imaging capabilities, including reduced patient dose, 3-D rotation angiography acquisitions table side, and stent enhancement software. This video tour of the system was created at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting. For more information: www.shimadzu.com/med/products/angio/index.html.
Corindus Vascular Robotics received U.S. Food and Drug Administration (FDA) 510(k) clearance for its CorPath GRX, the second generation of its vascular robotic system. The system builds upon the original CorPath platform, adding a significant number of key upgrades that increase precision, improve workflow and extend the capabilities and range of interventional procedures that can be performed robotically. These features include Active Guide Management, which enables control of the guide catheter along with robotic control of the guidewire and balloon or stent catheter, with 1 millimeter advancement, from the Control Console. This precise positioning will enable physicians to adjust guide catheter position during PCI procedures, and may expand use of CorPath to more complex cases. The new system also features a completely redesigned Bedside Unit, featuring an Extended Reach Arm and a touchscreen display to streamline workflow.
The CorPath GRX was displayed for the first time at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 conference. Read more about the FDA approval.